Work package 4: Phase Ia/b clinical trial in The Netherlands and Burkina Faso

Led by Leiden University Medical Center, The Netherlands

The main objectives of this work package are to:

• To evaluate the safety of three doses of increasing strength formulation of Shigella vaccine given at three time points in healthy Dutch and Burkinabe adults.

• To assess the immunogenicity of three doses of increasing strength formulation of Shigella vaccine given at three time points in healthy Dutch and Burkinabe adults.

Partner